Skip to main content
. 2023 Nov 22;38(47):e401. doi: 10.3346/jkms.2023.38.e401

Table 2. Results of laboratory, radiological, and histological evaluation for pediatric acute hepatitis of unknown etiology in Korea.

Variables Total (N = 270) Surveillance (n = 82) Control (n = 188) P value
AST, U/L 1,283.53 ± 3,025.67 1,782.06 ± 4,864.97 1,066.08 ± 1,661.51 0.197
ALT, U/L 1,255.00 ± 1,626.87 1,404.49 ± 2,512.29 1,189.80 ± 1,029.22 0.457
TB, mg/dL 2.70 ± 4.91 2.73 ± 4.66 2.68 ± 5.03 0.944
DB, mg/dL 2.59 ± 4.43 2.10 ± 3.79 2.86 ± 4.75 0.254
Albumin, g/dL 3.99 ± 1.80 3.87 ± 0.60 4.05 ± 2.12 0.472
PT-INR 1.68 ± 4.42 1.39 ± 0.89 1.81 ± 5.29 0.506
Total WBC, ×103/μL 9.08 ± 4.81 10.07 ± 5.35 8.65 ± 4.51 0.026*
Platelet, 103/uL 301.10 ± 140.37 286.70 ± 129.96 307.34 ± 144.54 0.270
hs-CRP, mg/L 6.25 ± 22.01 9.08 ± 29.39 4.95 ± 17.59 0.253
ESR, mm/hr 14.77 ± 17.21 15.33 ± 19.22 14.45 ± 16.04 0.733
Liver sonography 183 (67.8) 54 (65.9) 129 (68.6) 1.000
Normal 95 (51.9) 22 (40.7) 73 (57) 0.052
Hepatosplenomegaly 41 (22.4) 13 (24.5) 28 (21.7) 0.703
Gall bladder, duct abnormalitya 31 (16.9) 14 (25.9) 17 (13.2) 0.051
Portal edema 29 (15.8) 12 (22.2) 17 (13.2) 0.182
Increased echogenicity 13 (7.1) 4 (7.4) 9 (7.0) 1.000
Ascites 15 (8.2) 9 (17) 6 (4.7) 0.014
Liver CT 42 (15.6) 14 (17.1) 28 (14.9) 0.597
Normal 8 (19) 2 (14.3) 6 (23) 0.697
Hepatosplenomegaly 21 (50) 9 (64.3) 12 (42.9) 0.326
Gall bladder, duct abnormalitya 16 (38.1) 5 (35.7) 11 (39.3) 1.000
Portal edema 22 (52.4) 7 (50) 15 (53.6) 1.000
Ascites 18 (42.9) 5 (35.7) 13 (46.4) 0.742
Liver biopsy 23 (8.5) 8 (9.8) 15 (8.2) 0.637
Necrosis 1 (14.3) 2 (13.3)
Intrahepatic cholestasis 2 (13.3)

Values are presented as number (%) or mean ± standard deviation.

AST = aspartate transaminase, ALT = alanine transaminase, TB = total bilirubin, DB = direct bilirubin, PT-INR = prothrombin time – international normalized ratio, WBC = white blood cell count, CRP = C-reactive protein, hs-CRP = high-sensitivity C-reactive protein, ESR = erythrocyte sedimentation rate, CT = computed tomography.

aGB wall thickening, GB sludge, and intrahepatic duct dilatation.

*The P value is less than 0.05 in the analysis between the surveillance group (May to November 2022) and control subgroup (May to November 2021).